Development of Liquid Crystalline Nanoparticles for Effective Treatment of Herpes Keratitis

Key Points

• Liquid crystalline nanoparticles significantly enhance drug delivery efficiency in herpes keratitis treatment, showing promise for improved outcomes.
• In vitro experiments demonstrated that these nanoparticles could provide sustained release and localized treatment, enhancing therapeutic effectiveness.
• Topical treatments utilizing these nanoparticles may improve biocompatibility and patient compliance, reducing side effects compared to traditional therapies.
• The findings suggest a novel approach to manage herpes keratitis, indicating a potentially transformative impact on treatment strategies.